Category |

Industry News

Juul Hopes To Reinvent E-Cigarette Ads with 'Vaporize' Campaign

by Client Services |  Advertising Age recently ran a story on Juul's multimillion-dollar "Vaporize" campaign, which includes a brightly colored 12-unit billboard display that will hang above the streets of Times Square. Publications have branded Juul as the "iPhone of e-cigs" and their ads will feature 20- to 30-year-olds using the product on... Read More

Understanding the Proactive Healthcare Consumer

by Client Services |  Healthcare has been in a state of flux in recent times. With the rise of the Affordable Care Act, everything is shifting towards personal accountability. Individuals, employers and health insurance companies are all making a bigger push for preventative healthcare measures. The new healthcare landscape demands higher... Read More

Highest Spending Drug Classes through First Quarter 2015

by Client Services |  Advertisers in professional health journals spent over $141 million January through March 2015, according to Kantar Media. Top 5 Print Ad Drug Classes (Dollars): YTD March 2015 Antineoplastic Agents – $14.9 MM (+50%) Anticoagulants Oral – $5.6 MM (+15%) Diabetes Oral – $5.3 MM (-13%) Antivirals, Other – $4.6 MM (+104%) Diabet... Read More

Which Pharma Companies Have Spent the Most on Professional Print Ads through March 2015?

by Client Services |  Johnson & Johnson has maintained its spot at the top pharma company advertising in professional health journals by dollars, according to Kantar Media. The company makes up more than 5% of the total advertising share while its next closest competitor, Lilly, holds nearly 4% of professional print ad dollars spent. Top 5... Read More

Top Categories Advertising in Print Medical Journals 1Q 2015 (by Pages)

by Client Services |  Advertisers in professional health journals purchased 22,889 total ad pages through March 2015, according to Kantar Media. Cancer Therapy is the top drug class advertising by both pages and dollars, as it was in 2014. These antineoplastic agents make up almost 14% of total share in the market. Top 5 Print Ad Drug Classes... Read More

Top 5 Drugs Advertising in Professional Health Journals through March 2015

by Client Services |  Print advertising dollars in professional health journals reached over $141 million through March 2015, a nearly 6% decrease year-over-year, according to Kantar Media. Of the top ten products being advertised in professional health journals through March 2015, only three were on the list at this time in 2014. Top 5 Print... Read More

The Internet Empowers Healthcare Decisions of Your Target Patients

by Client Services |  170 million U.S. adults went online for health research in 2014, according to the Kantar Media 2014 Consumer Health Study. This new infographic shows you: Why do they go online? How do they go online? What do they do online? Click here to download this infographic filled with DTC advertising insights now. In addition,... Read More

New Data on E-cig Usage

by Client Services |  This week's release of results from the CDC's 2014 National Youth Tobacco Survey is making headlines, particularly in its findings that e-cigarette use among high-school students increased nearly 800%. Why? For teens, a New York Times story reports that, "A significant share said they were using the devices to ... Read More

Which Pharma Companies Have Spent the Most on Professional Print Ads through February 2015?

by Client Services |  Johnson & Johnson has maintained its spot at the top pharma company advertising in professional health journals by dollars, according to Kantar Media. The company makes up 7% of the total advertising share while Forest Laboratories comprises about 4%. Top 5 Print Ad Pharma Companies (Dollars): YTD February 2015 Johnson &... Read More

Highest Spending Drug Classes through February 2015

by Client Services |  Advertisers in professional health journals spent over $86 million January through February 2015, according to Kantar Media. Cancer Therapy is the top drug class advertising by both dollars and pages, as it was in both 2014 and 2013. These antineoplastic agents make up 11% of the total dollars spent on... Read More

What Are Doctors Doing on Computers?

by Client Services |  Beyond access the Internet and email, what tasks are doctors performing on their computers for work reasons? 85% of doctors use computers to research general medical issues or specific clinical situations, according to the most recent Sources & Interactions Study, (September 2014): Medical/Surgical Edition. Further,... Read More

Doctors Using Tablets for Professional Purposes

by Client Services |  A slim majority of doctors (53%) are using tablet devices for professional purposes, according to recent data from  the Sources & Interactions Study, September 2014 – Medical/Surgical Edition, and 47% of all doctors are using a tablet app for work reasons. Among doctors who are tablet users, 75% use apps for... Read More

How often do doctors consult the Internet after meeting with a patient?

by Client Services |  Doctors consult Internet-based resources regarding a specific patient conditions immediately after a patient consult an average of 4.4 times per week, according to the most recent edition of the Kantar Media Sources & Interactions Study (September 2014). Three in four physicians use the Internet after a patient consult... Read More

One-Third of Doctors Use a Consumer Social Network for Work Reasons

by Client Services |  More than two-thirds (69%) of physicians use at least one of the three types of social networks listed in the study, while 31% do not use any, according to the Sources & Interactions Study, September 2014 – Medical/Surgical Edition. This breaks down to 16% of doctors using all three types, 28% using 2 of the 3, and... Read More

Johnson & Johnson Spent More Than $2.5 Million Advertising in Medical Journals in January 2015

by Client Services |  Johnson & Johnson ended 2014 as the top pharma company advertising in medical journals and it's beginning 2015 in the same position. In January, Johnson & Johnson spent about $2.5 million advertising, comprising 6% of the total market share among all companies. Top 5 Print Ad Pharma Companies (Dollars): January 2015 Johns... Read More

Top Pharmaceutical Classes Advertising in Professional Health Journals in January 2015

by Client Services |  In the first month of 2015, print advertising dollars in professional health journals reached just over $41 million, a nearly 10% decrease year-over-year, according to Kantar Media. Similar to 2014, Cancer Therapy Products (Antineoplastic Agents) took the top spot as the most advertised product class. The top product... Read More

Top Pharma Classes Advertising in Medical Journals: January 2015

by Client Services |  There were 6,319 print advertising pages in medical journals in January 2015, a nearly 10% decrease year-over-year, according to Kantar Media. Antineoplastic agents for cancer therapy is the top drug class advertising by both pages and dollars, as it was in 2014. Further, that product class comprised about 16% of total... Read More

Over $1 Million Spent Advertising Trulicity in Medical Journals in January 2015

by Client Services |  It's a new year, which can often mean new pharmaceuticals making big investments advertising in print medical journals. For example, Trulicity—approved in September 2014 for Type 2 Diabetes treatment—has hit the ground running with more than a million dollar print journal ad expenditure. For that investment,... Read More

How Can You Reach Physicians?

by Client Services |  Colleagues and medical journals (accessed via print) continue to have the highest reach among doctors, according to the most recent Sources & Interactions Study, Medical/Surgical Edition. Understandably, the most far-reaching information sources differ among physicians of various specialties.  For example,... Read More

Which Pharma Companies Spent the Most in Print Journals in 2014?

by Client Services |  In 2014, Johnson & Johnson spent more than $34 million advertising its drug products in professional health journals, meaning it comprises 6% of the total market share among all companies. 2014 was Johnson & Johnson's second year in a row as the top spender. Both AstraZeneca and GlaxoSmithKline are new to the top... Read More

Next Page
-->